SCHEMBL4135570

SCHEMBL4135570

CC(C)CC(Oc1ccc(C#N)c(C(F)(F)F)c1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
AR P10275 18/20 0.49
PGR P06401 1/20 0.46
PPARG P37231 1/20 0.46
PPARA Q07869 1/20 0.46
RXRA P19793 1/20 0.45
RXRB P28702 1/20 0.45
RXRG P48443 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4142409 1.00 AR (0.49) ARPGRPPARGPPARARXRA
SCHEMBL4140812 0.88 AR (0.42) AR
SCHEMBL4148323 0.87 AR (0.41) AR
SCHEMBL4154536 0.87 AR (0.46) ARPGR
SCHEMBL4152164 0.86 AR (0.46) ARPGR
SCHEMBL4132827 0.86 AR (0.40) AR
SCHEMBL4140884 0.85 PPARG (0.52) ARPGRPPARGPPARA
SCHEMBL4489988 0.85 PPARG (0.52) ARPGRPPARGPPARA
SCHEMBL4133079 0.85 PPARG (0.52) ARPGRPPARGPPARA
SCHEMBL4149823 0.85 AR (0.45) ARPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7507860-B2 Androgen modulators PFIZER INC. (US) 2009-03-24 US claimed
US-20090192202-A1 ANDROGEN MODULATORS PFIZER INC 2009-07-30 US disclosed
US-20090192202-A1 ANDROGEN MODULATORS PFIZER INC 2009-07-30 US disclosed
US-20090192202-A1 ANDROGEN MODULATORS PFIZER INC 2009-07-30 US disclosed
US-7507860-B2 Androgen modulators PFIZER INC. (US) 2009-03-24 US disclosed
US-7507860-B2 Androgen modulators PFIZER INC. (US) 2009-03-24 US disclosed
US-7507860-B2 Androgen modulators PFIZER INC. (US) 2009-03-24 US disclosed
US-7473711-B2 Androgen modulators PFIZER INC. (US) 2009-01-06 US disclosed
US-20070197641-A1 Androgen modulators HU LAIN-YEN 2007-08-23 US disclosed
US-20070197642-A1 Androgen modulators WARNER-LAMBERT COMPANY LLC 2007-08-23 US disclosed
US-20070197641-A1 Androgen modulators HU LAIN-YEN 2007-08-23 US disclosed
US-20070197641-A1 Androgen modulators HU LAIN-YEN 2007-08-23 US disclosed
EP-1740533-A1 ANDROGEN MODULATORS Warner-Lambert Company LLC (US) 2007-01-10 EP disclosed
EP-1737813-A1 ANDROGEN MODULATORS Warner-Lambert Company LLC (US) 2007-01-03 EP disclosed
WO-2005102990-A1 ANDROGEN MODULATORS WARNER-LAMBERT COMPANY LLC (US) 2005-11-03 WO disclosed
WO-2005100305-A1 ANDROGEN MODULATORS WARNER-LAMBERT COMPANY LLC (US) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197641-A1 Androgen modulators AR, NR5A1, SHBG AR 1/4885PGR 43/4885PPARG 173/4885
US-20090192202-A1 ANDROGEN MODULATORS AR, NR5A1, SHBG AR 1/4885PGR 43/4885PPARG 173/4885
US-20070197642-A1 Androgen modulators CYP17A1, NR5A1, SHBG AR 4/4885PGR 48/4885PPARG 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.